- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | ENvue Medical Commences U.S. Production of UroShield and Begins Fulfilling UK Distributor Orders | 371 | ACCESS Newswire | Shipments to Peak Medical underway under agreement with multi-million-dollar minimum purchase commitments through 2029; follows September start of PainShield shipments in the U.S. ARLINGTON HEIGHTS... ► Artikel lesen | |
| Mo | ENvue Medical Issues Letter to Shareholders | 274 | ACCESS Newswire | Letter Highlights Inova Clinical Data, Hospital Customer Base and Leaner Operating Structure ARLINGTON HEIGHTS, IL / ACCESS Newswire / October 26, 2026 / ENvue Medical, Inc. (OTC PINK:FEED) ("ENvue... ► Artikel lesen | |
| 14.10. | ENvue Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 24.09. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.09.2026 | 530 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 24.09.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.09.2026ISIN NameCA60686A4090 MKANGO... ► Artikel lesen | |
| 16.09. | Envue Medical (FEED) Shares Fall 23% After Hours: Here's What Is Going On | 4 | Benzinga.com | ||
| ENVUE MEDICAL Aktie jetzt für 0€ handeln | |||||
| 15.09. | ENvue Medical, Inc.: ENvue Medical Provides Nasdaq Listing Update | 234 | GlobeNewswire (Europe) | TYLER, Texas, Sept. 15, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (Nasdaq: FEED) ("ENvue" or the "Company"), a medical technology company focused on innovative solutions for enteral feeding and... ► Artikel lesen | |
| 09.09. | ENvue Medical resumes PainShield shipments from U.S. facility | 1 | Investing.com | ||
| 02.09. | ENvue Medical, Inc.: ENvue Medical Selected to Exhibit ENvue Navigation Platform at Vizient Innovative Technology Exchange | 1 | GlobeNewswire (USA) | ||
| 01.09. | XFRA 56R: AUSSETZUNG/SUSPENSION | 296 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILENVUE MED INC. NEW... ► Artikel lesen | |
| 01.09. | XFRA NEW INSTRUMENTS AVAILABLE ON 01.09.2026 | 252 | Xetra Newsboard | The following instruments on XETRA do have their first trading 01.09.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 01.09.2026
Aktien
1 VGG863021256 SWVL Holdings Corp.
2... ► Artikel lesen | |
| 31.08. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 31.08.2026 | 748 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 31.08.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 31.08.2026ISIN NameDE000A0N3UD5 ROSTRA... ► Artikel lesen | |
| 31.08. | XFRA ISIN CHANGE | 271 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS63008J8844 ENvue Medical Inc. 31.08.2026 US63008J8760 ENvue Medical Inc. 01.09.2026 Tausch 12:1 ► Artikel lesen | |
| 28.08. | ENvue Medical announces 1-for-12 reverse stock split | 6 | Investing.com | ||
| 28.08. | ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split | 248 | GlobeNewswire (Europe) | TYLER, Texas, Aug. 28, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical technology company, today announced that a reverse stock split... ► Artikel lesen | |
| 19.08. | ENvue Medical: Revenue Jumps 275% As Hospital Adoption Offsets PainShield Production Shutdown | 5 | pulse2.com | ||
| 18.08. | ENvue Medical, Inc.: ENvue Medical Announces Exclusive UroShield Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million | 243 | GlobeNewswire (Europe) | TYLER, Texas, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical device company, today announced a new exclusive distribution agreement... ► Artikel lesen | |
| 17.08. | ENvue Medical, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 12.08. | ENvue Medical secures up to $50M equity facility to fund growth plans | 3 | Seeking Alpha | ||
| 12.08. | ENvue Medical secures $50M equity financing facility | 5 | Investing.com | ||
| 12.08. | ENvue Medical, Inc.: ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions | 377 | GlobeNewswire (Europe) | TYLER, Texas, Aug. 12, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical technology company, today announced that it has entered into... ► Artikel lesen |
1 2 3 Weiter >>
49 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 42,890 | 0,00 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| TELADOC HEALTH | 7,558 | -0,55 % | Stifel hebt Kursziel für Teladoc Health an: Kostensenkungen stärken Margen | ||
| BECTON DICKINSON | 176,70 | +0,31 % | BD begins US rollout of next-gen liver stent graft | ||
| SERNOVA BIOTHERAPEUTICS | 0,067 | +1,52 % | Sernova Biotherapeutics, Inc.: Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial | TORONTO and GERMANTOWN, Md., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO) and Seraxis Holdings, Inc. ("Seraxis") today announced... ► Artikel lesen | |
| CERENOME | 1,458 | -0,14 % | Cerenome completes enrollment in glioblastoma drug trial | ||
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | NuGen Medical Devices Inc.: NuGen Announces Loan Agreement with Sol-Millennium Medical HK Limited | Toronto, Ontario--(Newsfile Corp. - September 21, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is pleased to announce the entering into of a loan agreement (the "Loan Agreement")... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,120 | +8,72 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| SPINEWAY | 0,083 | 0,00 % | Spineway: H1 2026 results | H1 2026 results Continued growth Stable resultsStrong embedded growth driversIssuance of straight bonds to finance future growth In thousands of eurosConsolidated financial statements - UnauditedH1... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| TANDEM DIABETES | 17,700 | +0,57 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| CO-DIAGNOSTICS | 0,369 | +0,52 % | Co-Diagnostics' Joint Venture CoSara Diagnostics Completes Clinical Study and Regulatory Submission for Point-of-Care Tuberculosis Test, Sets Stage for Commercial Launch in India | CDSCO Clearance and Commercial Launch in India Anticipated Before Year-End 2026Study Demonstrated 97.3% Sensitivity and 96.0% SpecificityConsistent Performance Across Three Test BatchesIntegrated Mobile... ► Artikel lesen | |
| QUIDELORTHO | 11,315 | -4,56 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,190 | 0,00 % | Oppenheimer reiterates Veru stock rating ahead of obesity trial data | ||
| LIFEWARD | 5,910 | -0,51 % | Lifeward Ltd. - 8-K, Current Report |
Das Unternehmen ENVUE MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,620 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ENVUE MEDICAL INC finden Sie auf Wallstreet Online.